Reporter Liao Chieh-Yu / Taipei 

Probiotic raw material supplier SYNBIO TECH INC. (TPEx. 1295) will be listed on the over-the-counter market in May, with a tentative underwriting price of NT$60 per share. General Manager Yang Chuan-Hsien indicated that the revenue growth target for Taiwan's health supplement OEM industry is 10% annually. The feed additive business aims for double-digit growth in Southeast Asia and Central and South America, and overall, the company is optimistic about achieving double-digit growth for the entire year.

Spokesperson, Zhang Hsiu-Ju, stated that last year's revenue and profits both grew significantly, mainly due to successful market expansion of animal feed additives in Southeast Asia, along with product upgrades in collaboration with well-known domestic probiotic manufacturers. Additionally, the increase in probiotic strains in the Chinese market contributed to revenue and improved gross margins, with this year's operational target aiming for double-digit growth.

Chairman Yang Lian-Chuan mentioned that the company's sales revenue distribution is 46% from Taiwan, 30% from China, 15% from Southeast Asia, and less than 1% from the United States, thus not being affected by the Trump tariff war.

SYNBIO TECH INC. stated that its products span diverse fields including human health supplements, functional foods, pet health products, animal feed additives, and plant preservatives. In terms of human health, the company continues to deepen its scientific basis through clinical validation. In animal health applications, probiotics effectively improve gut microbiota, enhance digestive efficiency, and boost immunity, providing dual benefits of health and economic gains for the livestock industry, while also aligning with the global trend of improving livestock product quality and replacing antibiotics.

According to MarketsandMarkets, the global probiotic market is expected to exceed USD 105.7 billion by 2029, with a compound annual growth rate of 8.2%. Additionally, Euromonitor analysis predicts that the global dietary supplement market will grow from USD 133.7 billion in 2023 to USD 165 billion in 2027, with probiotics and dietary fiber products seen as key drivers.

SYNBIO TECH INC. noted that in recent years, rising health awareness among consumers has made nutritional supplements no longer exclusive to the elderly or patients; younger demographics and health-conscious individuals are increasingly participating, driving rapid market demand growth. The company continues to develop a new generation of probiotic products through in-depth analysis of microbiomes and collaborates across disciplines such as preventive medicine and clinical testing, continually enhancing product professionalism and application breadth to expand commercial benefits.

Last year, SYNBIO TECH INC. reported consolidated revenue of NT$989 million, with a net profit after tax of NT$170 million and earnings per share (EPS) of NT$5.43, both reaching new highs. For the first two months of this year, the cumulative consolidated revenue was NT$137 million, a year-on-year increase of 5.96%.